Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.
about
Structural and Biochemical Characterization of the Vaccinia Virus Envelope Protein D8 and Its Recognition by the Antibody LA5Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 ProteinAntibodies for biodefenseProtection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies.Smallpox vaccines: targets of protective immunity.Enhanced efficacy of cidofovir combined with vaccinia immune globulin in treating progressive cutaneous vaccinia virus infections in immunosuppressed hairless miceAn epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodiesT cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Murine anti-vaccinia virus D8 antibodies target different epitopes and differ in their ability to block D8 binding to CS-EStructural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses - Target Selection and Optimized ScreeningUnusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.The Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-GlucoseSerro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans.The strategic use of novel smallpox vaccines in the post-eradication world.Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsVaccinia virus A6 is essential for virion membrane biogenesis and localization of virion membrane proteins to sites of virion assemblyProtective murine and human monoclonal antibodies against eczema vaccinatumCharacterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets.
P2860
Q27679281-8D646BCC-6046-4D27-8056-7E0496A54E8BQ27684713-EC5B3A4F-8187-4402-BA5C-3B43EE3F55B8Q28394941-B27E8E87-EAD6-4C27-B10B-CA74F8BEF8DDQ34469836-A5C397A9-6075-4514-A5AA-A19B1FF63316Q34780607-3B3866A3-6265-4161-B886-6B787107C135Q34922842-9BC49ED3-D288-40D8-BF22-55B0981B76A1Q35186318-68B45191-6453-4FFB-92C7-0DE81073E6C3Q35206861-7B507C95-A831-4BCF-90C0-566AA7F09D6EQ35489874-7382AE29-8388-4F84-89E5-053703F93426Q35760869-D69FCA88-2145-4A99-AA04-7DD4D6557BB8Q35941208-3304450E-96E4-4986-95AB-315FE928C662Q36559797-853D34A0-0860-4934-BCF0-17D84220EA81Q36811880-ADFBAB95-4D82-46F7-A3FA-DBA7C5950FB5Q36878858-02F53BD0-C75E-4A7F-AFA7-8483BE8729E0Q37539293-8BE72BC8-199D-4EBB-BE4A-C92CE7B2D6B2Q37909421-565FB7D5-C7D0-42C9-9EF8-B9369643AB0DQ40494092-7469136B-CD35-4CED-AC54-F242580D2A40Q42122764-FBD9D46C-EBEE-49E9-AA4E-7FF8A6D94B1AQ42638248-AB657E0C-38CA-4412-8C05-5F9852BDF3B6Q52725450-B4CDD771-1E64-42DB-ADC1-647FFA273E12
P2860
Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Combination therapy of vaccini ...... odies in a small animal model.
@ast
Combination therapy of vaccini ...... odies in a small animal model.
@en
type
label
Combination therapy of vaccini ...... odies in a small animal model.
@ast
Combination therapy of vaccini ...... odies in a small animal model.
@en
prefLabel
Combination therapy of vaccini ...... odies in a small animal model.
@ast
Combination therapy of vaccini ...... odies in a small animal model.
@en
P2093
P2860
P356
P1433
P1476
Combination therapy of vaccini ...... odies in a small animal model.
@en
P2093
John Laudenslager
Lilia Koriazova
Lindsay Crickard
Megan M McCausland
Mohammed Rafii-El-Idrissi Benhnia
Ralph Kubo
Shane Crotty
Shinichiro Kato
Steven W Granger
Tomoyuki Tahara
P2860
P304
P356
10.3851/IMP1573
P577
2010-01-01T00:00:00Z